Table 2 Comparation of visual acuity and anatomic outcomes between inverted flap group and non-inverted flap group
|  | Inverted flap group (N = 11) | Non-inverted flap group (N = 15) | P |
|---|---|---|---|
Age/years mean ± SD (range) | 54.64 ± 7.21 (41.00 to 66.00) | 58.40 ± 10.52 (43.00 to 80.00) | 0.32 |
No. of FD/ n (%) | 5 (45.45%) | 4 (26.67%) | 0.42& |
No. of LMH/ n (%) | 9 (81.82%) | 10 (66.67%) | 0.66& |
Axial length/mm mean ± SD(range) | 29.51 ± 1.32 (26.97 to 31.65) | 29.55 ± 1.33 (27.63 to 31.94) | 0.93 |
Follow-up period/ monthsmean ± SD (range) | 9.20 ± 3.31 (4.30 to 16.60) | 11.86 ± 5.14 (3.13 to 18.33) | 0.19# |
Preoperative | |||
 BCVA/logMARmean ± SD(range) | 1.02 ± 0.38 (0.52 to 1.85) | 0.93 ± 0.51 (0.30 to 1.85) | 0.66 |
 MMT/µm mean ± SD(range) | 438.36 ± 137.51 (169.00 to 609.00) | 532.53 ± 246.85 (261.00 to 1241.00) | 0.07# |
 CFT/µm mean ± SD(range) | 237.91 ± 215.52 (101.00 to 840.00) | 338.73 ± 200.96 (123.00 to 766.00) | 0.35# |
Last follow-up | |||
 BCVA/logMAR mean ± SD(range) | 0.66 ± 0.52 (0.10 to 1.85) | 0.55 ± 0.49 (0.10 to 1.85) | 0.50# |
 MMT /µm mean ± SD(range) | 215.36 ± 100.77 (69.00 to 407.00) | 249.36 ± 83.25 (143.00 to 376.00) | 0.37 |
 CFT/µmmean ± SD(range) | 138.46 ± 89.20 (24.00 to 353.00) | 138.20 ± 63.81 (40.00 to 298.00) | 0.99 |